Healthcare -
Biotechnology - NASDAQ - US
$ 9.08
4.73 %
$ 531 M
Market Cap
-3.27
P/E
CGEM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CGEM - Cullinan Oncology, Inc.
40.8 M
LAST VALUE
-61.06%
2 YEAR CAGR
326.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR